In the early 1990's or late 1980's I first heard of AMGN, but failed to invest. When it split the first time in the 1990's I thought it did much better than I though, but didn't see how it could continue to do so. I was wrong the whole decade, never got in and by the end of that decade it split a total of 48 to 1 and was selling for nearly $100 at the end of the decade. I initially could have bought it for under $15 as I remember it.
I don't know that IMGN offers that much potential today, but I certainly believe it has a long way to go. IMGN's market cap is just under $3 billion today, SGEN's is over $37 billion, I believe a comparison of the technology would show them comparable, in some ways IMGN's superior, SGEN having more approved products. My point is IMGN has the potential to grow to at least where SGEN is today, while SGEN is being bought out at essentially that price. If it takes a decade to reach roughly half of SGEN's market cap today, that's still over 6 times it's current market cap, allowing for dilution, let's say the share price is five times what it currently is. Who would complain about that sort of growth.
Meanwhile for those of us who bought in at around $5 on average, we'd be looking at a ten banger, or more. I've spoken of NWBO having tremendous potential, and frankly I believe it greater than IMGN at its current bargain basement price, but risk must be considered as well, and I like the idea of being invested nearly equally in both.
Gary
Market Data 
Markets 
AI
